AIM2 and rheumatoid arthritis: Recently, Mendez-Frausto et al. [26] observed that AIM2 was reduced at a systemic level in patients with RA, and the monocytes of RA patients were found to be prone to releasing IL-1β in the absence of AIM2 inflammasome signals.